Imaging findings provide clues about biological behavior and possible cancer risk. Communication with the pancreatic duct, wall nodules, septations, and duct dilation are especially important features to characterize on computed tomography or magnetic resonance imaging. Interpreting these findings together helps clinicians distinguish lesions more suitable for surveillance from those that may warrant consideration of surgical treatment.
Clinical history helps place a cystic finding in context, particularly when distinguishing inflammation-related collections from cystic neoplasms. A history suggesting pancreatic inflammation can support one diagnostic direction, whereas imaging features may raise concern for a precancerous or malignant process. Combining this background with imaging improves classification rather than relying on a single observation.
Concern increases when evaluation identifies features such as wall nodules or pancreatic duct dilation, because these findings contribute to risk assessment. Septations and duct communication also help characterize the lesion and may influence its classification. No single feature replaces an integrated assessment using clinical history, cross-sectional imaging, and, when appropriate, endoscopic ultrasound.
Computed tomography and magnetic resonance imaging provide complementary characterization of the lesion and its relationship to the pancreatic duct. Endoscopic ultrasound offers another level of assessment and can support tissue or fluid evaluation. Using these modalities in the broader diagnostic workup allows clinicians to examine structural features, refine classification, and guide individualized management.
Endoscopic ultrasound can provide detailed assessment while also enabling collection of cyst fluid for analysis and cytology. Fluid analysis may support diagnostic classification, and cytology examines sampled cellular material for additional evidence. This approach is particularly useful when imaging alone does not provide enough information to determine whether surveillance or possible surgical treatment should be considered.
Management depends on the lesion’s classification and estimated risk rather than on the presence of a cyst alone. Findings that support a benign or inflammation-related process may lead to surveillance, while features suggesting a precancerous or malignant cystic neoplasm may prompt consideration of surgery. Clinical history, imaging, fluid analysis, and cytology inform this individualized decision.